Antares Pharma Inc. (ATRS)

Trade ATRS now with

RTTNews Articles

Date	Headline
5/16/2013 12:40:29 PM	Antares Pharma To Present At Bank Of America Conference ; Webcast At 1:40 PM
5/8/2013 7:12:21 AM	Antares Pharma Q1 Net Loss $3.40 Mln Or $0.03 Per Share
4/16/2013 8:30:38 AM	Antares Pharma Announces Ssuance Of New Patent On VIBEX Device Platform
4/5/2013 7:54:58 AM	Antares Gets Notice Of Allowance For New Patent On VIBEX QuickShot Device
4/5/2013 7:31:01 AM	Antares Pharma Announces Notice Of Allowance For New Patent On VIBEX QuickShot Device
3/13/2013 7:31:14 AM	Antares Pharma Q4 12 Earnings Conference Call At 8:30 AM ET
3/13/2013 7:01:20 AM	Antares Pharma Posts Q4 Loss Per Share Of $0.04 Vs. Breakeven Last Year
3/6/2013 7:40:45 AM	Antares Pharma To Present At Cowen And Company Conference ; Webcast At 8:40 AM
2/27/2013 10:24:57 PM	ZGNX Soars, ATRS Gets Date With FDA, AVEO, TTNP To Face Panel, CRDC Takes Heart
2/27/2013 7:39:47 AM	FDA Accepts Antares Pharma's NDA For Otrexup - Quick Facts
2/27/2013 7:32:49 AM	Antares Pharma To Present At RBC Capital Conference; Webcast At 8:30 AM
2/27/2013 7:31:34 AM	Antares Pharma Announces FDA Acceptance Of NDA For OTREXUP
12/18/2012 12:57:55 AM	Daily Dose: TZYM Plunges, GALE Announces Offering, GSK, QDEL Receive Clearance
12/17/2012 9:23:59 AM	Antares Pharma Completes Submission Of NDA For OTREXUP To FDA = Quick Facts
12/17/2012 9:01:32 AM	Antares Pharma Submits NDA To FDA For OTREXUP
12/12/2012 2:55:18 PM	Antares Pharma To Present At The Oppenheimer Conference; Webcast At 3:55 PM ET
11/13/2012 7:04:12 AM	Antares Pharma Reports Positive Results From Final MTX Medi-Jet Clinical Study
11/7/2012 7:32:33 AM	Antares Pharma Q3 12 Earnings Conference Call At 8:30 AM ET
11/7/2012 7:09:09 AM	Antares Pharma Q3 Loss/Share Widens To $0.03 From $0.01 Last Year
10/9/2012 1:36:08 PM	Antares Pharma Closes Stock Offering

Previous 20 Headlines